Oxinas Partners Wealth Management LLC Pfizer Inc Transaction History

Oxinas Partners Wealth Management LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	SELL	$25.26 - $29.6 $53,626 - $62,840	-2,123 Reduced 22.7%	7,231 $202,000
Q1 2024 Apr 18, 2024	SELL	$25.89 - $29.73 $22,757 - $26,132	-879 Reduced 8.59%	9,354 $259,000
Q4 2023 Jan 22, 2024	SELL	$26.13 - $33.94 $30,101 - $39,098	-1,152 Reduced 10.12%	10,233 $294,000
Q3 2023 Oct 25, 2023	SELL	$32.09 - $37.51 $16,430 - $19,205	-512 Reduced 4.3%	11,385 $377,000
Q2 2023 Jul 14, 2023	BUY	$36.12 - $41.79 $219,754 - $254,250	6,084 Added 104.66%	11,897 $436,000
Q1 2023 Apr 12, 2023	SELL	$39.39 - $51.28 $19,813 - $25,793	-503 Reduced 7.96%	5,813 $237,000
Q4 2022 Jan 17, 2023	SELL	$41.75 - $54.5 $4,425 - $5,777	-106 Reduced 1.65%	6,316 $0
Q3 2022 Oct 17, 2022	BUY	$43.76 - $53.42 $2,538 - $3,098	58 Added 0.91%	6,422 $281,000
Q2 2022 Jul 15, 2022	BUY	$46.53 - $55.17 $1,535 - $1,820	33 Added 0.52%	6,364 $334,000
Q1 2022 Apr 20, 2022	SELL	$45.75 - $56.69 $777 - $963	-17 Reduced 0.27%	6,331 $328,000
Q4 2021 Jan 19, 2022	SELL	$41.32 - $61.25 $15,247 - $22,601	-369 Reduced 5.49%	6,348 $375,000
Q3 2021 Nov 01, 2021	SELL	$39.25 - $50.42 $3,061 - $3,932	-78 Reduced 1.15%	6,717 $289,000
Q2 2021 Jul 26, 2021	SELL	$35.91 - $40.68 $57,886 - $65,576	-1,612 Reduced 19.17%	6,795 $266,000
Q1 2021 May 04, 2021	SELL	$33.49 - $37.77 $7,501 - $8,460	-224 Reduced 2.6%	8,407 $305,000
Q4 2020 Jan 19, 2021	BUY	$33.47 - $42.56 $288,879 - $367,335	8,631 New	8,631 $318,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Oxinas Partners Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Oxinas Partners Wealth Management LLC with notifications on news.